Monocytes (CD14+ fraction) and primary skin fibroblasts from CHM patients offer research material to indirectly evaluate the effect of different mutations on the disease phenotype, as loss of function mutations in the CHM gene are present in every tissue of affected individuals. This evidence concerns the gene CD14 and choroideremia.